A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer
BeOne Medicines
BeOne Medicines
Genmab
Akeso
Eli Lilly and Company
Inhibrx Biosciences, Inc
Innovent Biologics (Suzhou) Co. Ltd.
Nelum Corp
Merck Sharp & Dohme LLC
Actuate Therapeutics Inc.